AKBA vs HUBS · rev $102.7M vs P/E 96, rev $1.79B
Akebia Ther (AKBA) versus HubSpot Inc (HUBS) — a side-by-side from cached financials, not a winner call.
Akebia Ther (AKBA) is a drug manufacturers - specialty & generic company listed on US.
HubSpot Inc (HUBS) is a software - application company listed on NYSE.
Latest reported AKBA revenue for 2026-06-30 was $102.7M. Net income was -$18.0M. Revenue was up 91.8% from 2026-03-31 to 2026-06-30. AKBA currently screens at market cap $260.1M.
Latest reported HUBS revenue for 2026-06-30 was $1.79B. Net income was $75.9M. HUBS currently screens at market cap $9.36B and trailing P/E 96.2.
AKBA currently screens at market cap $260.1M. HUBS currently screens at market cap $9.36B and trailing P/E 96.2.
Not investment advice. Open the AKBA and HUBS stock pages for the full models.
Not investment advice.